PURPOSE: Chronic infection with schistosomiasis has been clearly associated with the development of bladder cancer, and infestation is associated with a high incidence of colorectal cancer in endemic populations. Despite this association, the potential role of alterations in tumor suppressor genes colorectal cancers has never been evaluated in an endemically infected population. The aim of this paper was to compare histopathologic and genetic changes in schistosomal colitis-associated colorectal cancer (SCC) with colorectal cancer in a group of patients from the same population not affected by the disease (NDCC). MATERIALS AND METHODS: Sixty patients were included in this study: SCC-40, NDCC-20. Data collected included age, sex, clinical presentation, presence of synchronous tumors, histopathology, and clinical stage. p53, DCC (deleted in colorectal cancer gene), and mismatch repair genes (MLH1 and MSH2) were studied using immunohistochemical staining. RESULTS: Patients with SCC were significantly younger than the NDCC group (34.52+/-11.22 years vs 50.73+/-12.75 years, p=0.02). Mucinous adenocarcinoma occurred significantly more frequently in SCC (35 vs 10%, p=0.02). SCC tumors were more frequently stage III or IV, and significantly more synchronous tumors were present in the affected group (SCC-8/40 vs NDCC-1/20, p=0.05). p53 staining was far more frequent in SCC (SCC-32/40 vs NDCC-8/20, p=0.006). DCC expression was similar in two groups. There were only four cases, three in SCC and one in NDCC, that showed microsatellite instability. CONCLUSION: The data suggest that schistosomal colitis is more commonly associated with earlier onset of multicentric colorectal cancer, high percentage of mucinous adenocarcinoma, and presents at an advanced stage. The identification of a higher incidence of altered p53 expression in the SCC group raises the possibility of an association between schistosomiasis and alterations in p53 activation as an inciting event in colorectal cancer development.
PURPOSE:Chronic infection with schistosomiasis has been clearly associated with the development of bladder cancer, and infestation is associated with a high incidence of colorectal cancer in endemic populations. Despite this association, the potential role of alterations in tumor suppressor genes colorectal cancers has never been evaluated in an endemically infected population. The aim of this paper was to compare histopathologic and genetic changes in schistosomal colitis-associated colorectal cancer (SCC) with colorectal cancer in a group of patients from the same population not affected by the disease (NDCC). MATERIALS AND METHODS: Sixty patients were included in this study: SCC-40, NDCC-20. Data collected included age, sex, clinical presentation, presence of synchronous tumors, histopathology, and clinical stage. p53, DCC (deleted in colorectal cancer gene), and mismatch repair genes (MLH1 and MSH2) were studied using immunohistochemical staining. RESULTS:Patients with SCC were significantly younger than the NDCC group (34.52+/-11.22 years vs 50.73+/-12.75 years, p=0.02). Mucinous adenocarcinoma occurred significantly more frequently in SCC (35 vs 10%, p=0.02). SCC tumors were more frequently stage III or IV, and significantly more synchronous tumors were present in the affected group (SCC-8/40 vs NDCC-1/20, p=0.05). p53 staining was far more frequent in SCC (SCC-32/40 vs NDCC-8/20, p=0.006). DCC expression was similar in two groups. There were only four cases, three in SCC and one in NDCC, that showed microsatellite instability. CONCLUSION: The data suggest that schistosomal colitis is more commonly associated with earlier onset of multicentric colorectal cancer, high percentage of mucinous adenocarcinoma, and presents at an advanced stage. The identification of a higher incidence of altered p53 expression in the SCC group raises the possibility of an association between schistosomiasis and alterations in p53 activation as an inciting event in colorectal cancer development.
Authors: A S Soliman; M L Bondy; B Levin; M R Hamza; K Ismail; S Ismail; H M Hammam; O H el-Hattab; S M Kamal; A G Soliman; L A Dorgham; R S McPherson; R P Beasley Journal: Int J Cancer Date: 1997-03-28 Impact factor: 7.396
Authors: G C Burmer; P S Rabinovitch; R C Haggitt; D A Crispin; T A Brentnall; V R Kolli; A C Stevens; C E Rubin Journal: Gastroenterology Date: 1992-11 Impact factor: 22.682
Authors: Ahmed A Abou-Zeid; Wael Khafagy; Deya M Marzouk; Ahmed Alaa; I Mostafa; M Aboul Ela Journal: Dis Colon Rectum Date: 2002-09 Impact factor: 4.585
Authors: David U Olveda; Yuesheng Li; Remigio M Olveda; Alfred K Lam; Thao N P Chau; Donald A Harn; Gail M Williams; Darren J Gray; Allen G P Ross Journal: Trop Med Surg Date: 2013-08-20
Authors: Hao Feng; Ai-Guo Lu; Xue-Wei Zhao; Ding-Pei Han; Jing-Kun Zhao; Lei Shi; Tobias S Schiergens; Serene M L Lee; Wen-Peng Zhang; Wolfgang E Thasler Journal: World J Gastroenterol Date: 2015-06-21 Impact factor: 5.742
Authors: Omer E H Salim; Hytham K S Hamid; Salwa O Mekki; Suleiman H Suleiman; Shakir Z Ibrahim Journal: World J Surg Oncol Date: 2010-08-13 Impact factor: 2.754